72: Treatment of Thyroid Cancer in Japan, with Dr. Takahiro Okamoto from Tokyo Women’s Medical University

A different approach to treating thyroid cancer compared to the U.S. Dr. Takahiro Okamoto helped write the Japanese guidelines on thyroid cancer.  He is Professor & Chair of the Department of Surgery at Tokyo Women's Medical University.  Key points from this episode include: * Most Western countries carry out total thyroidectomies, whereas in Japan, the approach is more conservative with a fundamental practice of hemithyroidectomy whenever possible. * By not doing a total thyroidectomy, this allows the patient to not avoid taking thyroid replacement medication. * Complete thyroidectomy is conducted when 80-90% of lymph nodes have metastasis. * I-131 treatment is decreasing despite cases of cancer increasing * For I-131 treatment, patients wait more than 6 months post surgery. * When receving I-131 treatment, patients be admitted to hospital for several days. * TSH suppression therapy is common in Western countries, whereas in Japan, measures are taken to avoid TSH suppression by not removing all of the thyroid. * Normal TSH in Japan is 4.3 or less.

Continue Reading72: Treatment of Thyroid Cancer in Japan, with Dr. Takahiro Okamoto from Tokyo Women’s Medical University

71: Hipotiroidismo – Causas, Síntomas, y Exámenes. Con la Dra. Gabriela Brenta de Buenos Aires

Hipotiroidismo: el tratamiento, pronóstico, posibles complicaciones, y cuándo contactar a un médico. La tiroides produce hormonas que controlan la forma como cada célula en el cuerpo usa la energía. Este proceso se denomina metabolismo. Hipotiroidismo es una afección en la cual la glándula tiroides no produce suficiente hormona tiroidea. Esta afección a menudo se llama tiroides hipoactiva.

Continue Reading71: Hipotiroidismo – Causas, Síntomas, y Exámenes. Con la Dra. Gabriela Brenta de Buenos Aires

70: Cáncer de Tiroides, con la Dra Ines Califano de Universidad de Buenos Aires

Cáncer de Tiroides, con la Dra Ines Califano de Universidad de Buenos Aires Reduzca la ansiedad durante el tratamiento del cáncer de tiroides En esta entrevista, discutimos lo siguiente: 1. ¿Qué es un nódulo? 2. ¿Qué sucede durante ecografia? 3. ¿Qué sucede durante la oja fina? 4. Si es cáncer, ¿siempre hace la cirugía? 5. Si no es cáncer, ¿algunas veces hace cirugía?

Continue Reading70: Cáncer de Tiroides, con la Dra Ines Califano de Universidad de Buenos Aires

69: For Some Thyroid Cancer Patients, No Surgery is the Best Treatment – Dr. Allen Ho from Cedars Sinai

Undesired consequences and a patient’s profession should weigh heavily in the decision to have thyroid surgery, or not. Dr. Allen Hois a fellowship-trained head and neck surgeon who focuses on…

Continue Reading69: For Some Thyroid Cancer Patients, No Surgery is the Best Treatment – Dr. Allen Ho from Cedars Sinai

68: Is There a Stigma to Choosing Active Surveillance? Dr. Louise Davies from The Dartmouth Institute

The past year has been fascinating and highly fruitful year for Dartmouth Institute Associate Professor Louise Davies, MD, MS. A 2017-2018 Fulbright Global Scholar, Davis spent several months in Japan…

Continue Reading68: Is There a Stigma to Choosing Active Surveillance? Dr. Louise Davies from The Dartmouth Institute

67: Molecular Profiling and Unnecessary Thyroid Surgeries with Jennifer Kuo from Columbia University

One-third of all thyroid nodule fine needle aspirations come back indeterminate. When surgery is performed on these cases, pathology of the thyroid reveals that many times the nodule is benign.  Through molecular profiling, patients with indeterminate thyroid nodules, can now avoid unnecessary surgery and get more accurate pathology results from the fine needle aspiration. Are you a patient and your doctor has said your thyroid nodule is indeterminate and is recommending surgery as an option?  The key is, to confirm that molecular profiling was performed.    Jennifer Kuo, MD is Director of the Thyroid Biopsy Program, Director of the Endocrine Surgery Research Program, and Instructor in Surgery, at the Columbia University Medical Center. 

Continue Reading67: Molecular Profiling and Unnecessary Thyroid Surgeries with Jennifer Kuo from Columbia University

66: New Research Reveals Thyroid Surgery Errors 5x More Frequent Than Reported with Dr. Maria Papaleontiou from Michigan Medicine

Scheduled to publish next month, the statistics show thyroid surgery much less safe than thought. The findings that 12% of patients overall had thyroid surgery specific complications is concerning, but more concerning is surgeons quote a 1 to 3 percent rate of error. In the case of surgery for metastatic thyroid cancer, the error rate skyrockets to 23%. Dr. Maria Papaleontiou is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes.

Continue Reading66: New Research Reveals Thyroid Surgery Errors 5x More Frequent Than Reported with Dr. Maria Papaleontiou from Michigan Medicine

65: Thyroid Surgery? Be Careful, Not All Surgeons Are Equal and Here is Why with Dr. Ralph P. Tufano from Johns Hopkins School of Medicine

If you select carefully, the unwanted errors of thyroid surgery can be avoided. Dr. Ralph P. Tufano is the Director of the Division of Head and Neck Endocrine Surgery at The Johns Hopkins School of Medicine, and conducts thyroid and parathyroid surgery with a focus on optimizing outcomes. In this interview, items discussed include: * the emotional burden of being diagnosed with cancer and the haste that sometimes follows * the unnecessary damage of thyroid surgery, including the cutting of the laryngeal nerve resulting in vocal cord paralysis, low calcium levels and a need to supplement calcium and Vitamin D for life, and leaving residual disease behind * knowing your risk factor and finding the right medical team to address it

Continue Reading65: Thyroid Surgery? Be Careful, Not All Surgeons Are Equal and Here is Why with Dr. Ralph P. Tufano from Johns Hopkins School of Medicine

64: 1 in 3 People Die With Thyroid Cancer — Not From with Dr. Seth Landefeld from UAB

1 in 3 People Die With Thyroid Cancer The USPSTF upholds its 1996 recommendation against screening for thyroid cancer among asymptomatic adults. The USPSTF commissioned the systematic review due to the rising incidence of thyroid cancers against a background of stable mortality, which is suggestive of over-treatment. And in view of the results, the task force concluded with “moderate certainty” that the harms outweigh the benefits of screening.

Continue Reading64: 1 in 3 People Die With Thyroid Cancer — Not From with Dr. Seth Landefeld from UAB

63: Diagnosed With Thyroid Cancer? Stop & Do Not Rush Into Surgery – Dr. Bryan McIver – Moffitt Cancer Center

If your thyroid cancer is not aggressive, taking your time, and vetting surgeons and exploring treatment options is your best choice. Bryan McIver, MD, PhDDr. McIver contributes to Moffitt Cancer…

Continue Reading63: Diagnosed With Thyroid Cancer? Stop & Do Not Rush Into Surgery – Dr. Bryan McIver – Moffitt Cancer Center